Badihian Negin, Riahi Roya, Goli Parvin, Badihian Shervin, Poursafa Parnian, Kelishadi Roya
Child Growth and Development Research Center, Research Institute for Primordial Prevention of Non-Communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran.
Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Autoimmun Rev. 2021 Jun;20(6):102823. doi: 10.1016/j.autrev.2021.102823. Epub 2021 Apr 15.
Both genetic and environmental factors play roles in Multiple Sclerosis (MS) etiopathogenesis. The relationship between prenatal/perinatal factors/exposures and future MS occurrence in the offspring remains controversial. Here, we aimed to review the available evidence on prenatal/perinatal factors associated with later MS occurrence.
We performed systematic search of PubMed, Web of Science, and Scopus from inception to October 2020. We included original observational studies conducted on human participants addressing the association between prenatal/perinatal factors and MS occurrence. Data were extracted according to the PRISMA guideline. The adjusted odds ratio (OR) with 95% confidence interval (CI) was considered as the desired effect size. The heterogeneity was evaluated by Cochran's Q and I and the publication bias was assessed. We excluded gestational/neonatal vitamin D level, season of birth, and latitude because of recently published systematic reviews/meta-analyses on these subjects.
Overall, 2306 records were identified in the primary search. After excluding irrelevant studies, we evaluated 34 studies with contributing data on 100 prenatal/perinatal factors associated with an increased or decreased risk of MS occurrence. In the meta-analyses, we found no statistically significant associations between later MS occurrence in offspring and prenatal smoking exposure (OR = 1.01, 95% CI = 0.77-1.34), mode of delivery (OR = 0.90, 95% CI = 0.52-1.56), birth order (OR = 0.85, 95% CI = 0.72-1.00), and maternal age (OR = 1.34, 95% CI = 0.88-2.04). Paternal age and parents' marital status at the time of childbirth, maternal preeclampsia/ toxemia, forceps use, birth weight, plurality, and preterm birth were the other most studied factors, and none reported to affect MS risk.
We found that prenatal smoking exposure, mode of delivery, birth order, and maternal age do not affect risk of future MS development. Moreover, most of the other investigated factors were reported not to affect MS risk in the offspring.
遗传因素和环境因素在多发性硬化症(MS)的病因发病机制中均起作用。产前/围产期因素/暴露与后代未来发生MS之间的关系仍存在争议。在此,我们旨在综述与MS后期发生相关的产前/围产期因素的现有证据。
我们对PubMed、科学网和Scopus从创刊至2020年10月进行了系统检索。我们纳入了针对人类参与者进行的关于产前/围产期因素与MS发生之间关联的原始观察性研究。数据根据PRISMA指南进行提取。将调整后的比值比(OR)及其95%置信区间(CI)视为预期的效应量。通过Cochran's Q和I²评估异质性,并评估发表偏倚。由于最近发表了关于这些主题的系统评价/荟萃分析,我们排除了孕期/新生儿维生素D水平、出生季节和纬度。
总体而言,在初步检索中识别出2306条记录。排除不相关研究后,我们评估了34项研究,这些研究提供了与MS发生风险增加或降低相关的100个产前/围产期因素的数据。在荟萃分析中,我们发现后代后期发生MS与产前吸烟暴露(OR = 1.01,95%CI = 0.77 - 1.34)、分娩方式(OR = 0.90,95%CI = 0.52 - 1.56)、出生顺序(OR = 0.85,95%CI = 0.72 - 1.00)和母亲年龄(OR = 1.34,95%CI = 0.88 - 2.04)之间无统计学显著关联。父亲年龄、分娩时父母的婚姻状况、母亲先兆子痫/毒血症、产钳使用、出生体重、多胎妊娠和早产是其他研究最多的因素,均未报告会影响MS风险。
我们发现产前吸烟暴露、分娩方式、出生顺序和母亲年龄不会影响未来MS发生的风险。此外,其他大多数研究因素均未报告会影响后代的MS风险。